Genitourinary Cancer

Genitourinary cancer is any cancer of the genitourinary system, including the bladder, prostate, kidneys, testicles, penis, ureter and adrenal glands. The treatment of these cancers are managed by urologists and/or oncologists, depending upon the type of treatment. Minimally-invasive techniques, as well as traditional chemoradiotherapy are utilized.

Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.

1:10
Beyond cancer treatment: nurse specialists in the clinic
Simon Crabb
4:25
Kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
Thomas Powles
1:55
Awaiting key results for enzalutamide and apalutamide in nmCRPC
Simon Crabb
2:04
How to involve patients in clinical decision making
Joe O'Sullivan
2:18
Not enough attention paid to bone health in prostate cancer
Simon Crabb
4:00
Upcoming therapies in the metastatic urothelial carcinoma space
Thomas Powles
2:55
Is RANGE providing the targeted therapies needed for urothelial cancer?
Thomas Powles
2:07
Weighing up efficacy data and QoL in clinical decision making
Joe O'Sullivan
3:37
Radium-223 after abiraterone: symptomatic skeletal events in patients with mCRPC
Joe O'Sullivan
1:14
The NCRI: an opportunity for patients and students to gain invaluable skills
Max Williamson
2:56
Why attend a medical congress: a patient and student perspective
Max Williamson
3:23
Improving the current chemotherapy standard: a role for DNA methyltransferase inhibitors
Simon Crabb
1:29
A patient-centered approach to cancer treatment decision-making
Bertrand Tombal
1:02
Current status of VEGF inhibitor/immunotherapy combinations in RCC
Bradley McGregor
1:31
Achieving better response rates in metastatic RCC
Bradley McGregor
2:24
Delaying disease progression in early, non-metastatic CRPC treatment
Bertrand Tombal
The content of VJOncology is intended for healthcare professionals